Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 53

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Anti–Methicillin-Resistant Staphylococcus aureus Nanoantibiotics

Labruère, Raphaël, Sona, A. J., Turos, Edward · 2019 · Frontiers in Pharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2019.01121

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 204

  1. Abeylath, 2007, Glycosylated polyacrylate nanoparticles by emulsion polymerization, Carbohydr. Polym., 70, 32, 10.1016/j.carbpol.2007.02.027 · DOI
  2. Abeylath, 2008, Glyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis, Bioorg. Med. Chem., 16, 2412, 10.1016/j.bmc.2007.11.052 · doi:10.1016/j.bmc.2007.11.052
  3. Abeylath, 2009, Nanobiotics to combat bacterial drug resistance, 425
  4. Alt, 2004, An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement, Biomaterials, 25, 4383, 10.1016/j.biomaterials.2003.10.078 · DOI · Paper page
  5. Ansari, 2011, Evaluation of antibacterial activity of silver nanoparticles against MSSA and MSRA on isolates from skin infections, Biol. Med., 3, 141, 10.4172/0974-8369.10000100 · doi:10.4172/0974-8369.10000100
  6. Ansari, 2012, Characterization of clinical strains of MSSA, MRSA and MRSE isolated from skin and soft tissue infections and the antibacterial activity of ZnO nanoparticles, World J. Microbiol. Biotechnol., 28, 1605, 10.1007/s11274-011-0966-1 · DOI
  7. Ayala-Núñez, 2009, Silver nanoparticles toxicity and bactericidal effect against methicillin-resistant Staphylococcus aureus: nanoscale Does Matter, Nanobiotechnology, 5, 2, 10.1007/s12030-009-9029-1 · DOI · Paper page
  8. Bagchi, 2012, Antimicrobial efficacy and biocompatibility study of copper nanoparticle adsorbed mullite aggregates, Mater. Sci. Eng. C, 32, 1897, 10.1016/j.msec.2012.05.011 · DOI
  9. Balogh, 2001, Dendrimer–silver complexes and nanocomposites as antimicrobial agents, Nano Lett., 1, 18, 10.1021/nl005502p · DOI · Paper page
  10. Bandow, 2009, New ways of killing the beast: prospects for inorganic–organic hybrid nanomaterials as antibacterial agents, ChemBioChem, 10, 2847, 10.1002/cbic.200900628 · DOI
  11. Barber, 1961, Methicillin-resistant staphylococci, J. Clin. Pathol., 14, 385, 10.1136/jcp.14.4.385 · DOI · Paper page
  12. Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat. Biotechnol., 33, 941, 10.1038/nbt.3330 · DOI · Paper page
  13. Bombelli, 2008, New cationic liposomes as vehicles of m-tetrahydroxyphenylchlorin in photodynamic therapy of infectious diseases, Mol. Pharm., 5, 672, 10.1021/mp800037d · doi:10.1021/mp800037d
  14. Brandt, 2012, Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine, Nanomed. Nanotech. Biol. Med., 8, 478, 10.1016/j.nano.2011.07.005 · DOI
  15. Bresee, 2011, Growth inhibition of Staphylococcus aureus by mixed monolayer gold nanoparticles, Small, 7, 2027, 10.1002/smll.201100420 · doi:10.1002/smll.201100420
  16. Brown, 2012, Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus, Appl. Environ. Microbiol., 78, 2768, 10.1128/AEM.06513-11 · DOI · Paper page
  17. Buhleier, 1978, Cascade- and nonskid-chain-like syntheses of molecular cavity topologies, Synthesis, 2, 155, 10.1055/s-1978-24702 · DOI · Paper page
  18. Cevher, 2006, Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres, Int. J. Pharm., 317, 127, 10.1016/j.ijpharm.2006.03.014 · DOI
  19. Chaloupka, 2010, Nanosilver as a new generation of nanoproduct in biomedical applications, Trends Biotechnol., 28, 580, 10.1016/j.tibtech.2010.07.006 · DOI · Paper page
  20. Chambers, 1997, Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications, Clin. Microbiol. Rev. Rev., 10, 781, 10.1128/CMR.10.4.781 · DOI · Paper page
  21. Chen, 2008, Functional Fe3O4/TiO2 core/shell magnetic nanoparticles as photokilling agents for pathogenic bacteria, Small, 4, 485, 10.1002/smll.200701164 · DOI · Paper page
  22. Cheng, 2008, External electrostatic interaction versus internal encapsulation between cationic dendrimers and negatively charged drugs: which contributes more to solubility enhancement of the drugs, J. Phys. Chem. B, 112, 8884, 10.1021/jp801742t · DOI
  23. Choi, 2012, Photosensitizer and vancomycin-conjugated novel multifunctional magnetic particles as photoinactivation agents for selective killing of pathogenic bacteria, Chem. Commun., 48, 4591, 10.1039/c2cc17766h · DOI
  24. Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
  25. Crossley, 2009, Staphylococci in human disease, 10.1002/9781444308464 · DOI
  26. Dallas, 2010, Magnetically controllable silver nanocomposite with multifunctional phosphotriazine matrix and high antimicrobial activity, Adv. Funct. Mater., 20, 2347, 10.1002/adfm.200902370 · DOI
  27. Dallas, 2011, Silver polymeric nanocomposites as advanced antimicrobial agents: classification, synthetic paths, applications, and perspectives, Adv. Colloid Interface Sci., 166, 119, 10.1016/j.cis.2011.05.008 · DOI · Paper page
  28. Dancer, 2008, The effect of antibiotics on methicillin-resistant Staphylococcus aureus, J. Antimicrob. Chemother., 61, 246, 10.1093/jac/dkm465 · DOI
  29. Daraee, 2016, Application of liposomes in medicine and drug delivery, Artif. Cells, Nanomed. Biotechnol., 44, 381, 10.3109/21691401.2014.953633 · DOI · Paper page
  30. Deresinski, 2005, Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey, Clin. Infect. Dis., 40, 562, 10.1086/427701 · DOI · Paper page
  31. Dinges, 2000, Exotoxins of Staphylococcus aureus, Clin. Microbiol. Rev., 13, 16, 10.1128/CMR.13.1.16 · DOI · Paper page
  32. Djokić, 2004, Deposition of silver oxysalts and their antimicrobial properties, J. Electrochem. Soc., 151, C359, 10.1149/1.1723498 · doi:10.1149/1.1723498
  33. Dospivova, 2012, Electrochemical behaviour of apoferritin encapsulating of silver(I) ions and its application for treatment of Staphylococcus aureus, Int. J. Electrochem. Sci., 7, 6378, 10.1016/S1452-3981(23)19488-0 · doi:10.1016/s1452-3981(23)19488-0
  34. Dugal, 2011, A novel strategy to control emerging drug resistant infections, J. Chem. Pharm. Res., 3, 584
  35. Dunnill, 2011, Nanoparticulate silver coated-titania thin films—photo-oxidative destruction of stearic acid under different light sources and antimicrobial effects under hospital lighting conditions, J. Photochem. Photobiol. A Chem., 220, 113, 10.1016/j.jphotochem.2011.04.001 · DOI
  36. Durairaj, 2010, Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin, Investig. Ophthalmol. Vis. Sci., 51, 5804, 10.1167/iovs.10-5388 · DOI
  37. Durán, 2008, Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3- hydroxyvalerate), Arch. Pharm. Res., 31, 1509, 10.1007/s12272-001-2137-7 · DOI
  38. Durán, 2016, Silver Nanoparticles: a new view on mechanistic aspects on antimicrobial activity, Nanomed. Nanotech. Biol. Med., 12, 789, 10.1016/j.nano.2015.11.016 · DOI · Paper page
  39. Edmiston, 2010, Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device, Am. J. Infect. Control., 38, 421, 10.1016/j.ajic.2009.09.010 · doi:10.1016/j.ajic.2009.09.010
  40. Elkhawass, 2014, Acute toxicity of different sizes of silver nanoparticles intraperitonally injected in BALB/c mice using two toxicological methods, Int. J. Pharm. Pharm. Sci., 7, 94
  41. Ellington, 2003, Intracellular Staphylococcus Aureus: a mechanism for the indolence of osteomyelitis, J. Bone Jt. Surg., 85, 918, 10.1302/0301-620X.85B6.13509 · DOI
  42. Ellington, 2006, Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis, J. Orthop. Res., 24, 87, 10.1002/jor.20003 · DOI
  43. Engler, 2012, Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant infections, Nano Today, 7, 201, 10.1016/j.nantod.2012.04.003 · DOI · Paper page
  44. Esmaeili, 2007, Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles, Nanomed. Nanotech. Biol. Med., 3, 161, 10.1016/j.nano.2007.03.003 · DOI
  45. Faraji, 2009, Nanoparticles in cellular drug delivery, Bioorg. Med. Chem., 17, 2950, 10.1016/j.bmc.2009.02.043 · DOI · Paper page
  46. Feng, 2000, A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus, J. Biomed. Mater. Res., 52, 662, 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 · DOI · Paper page
  47. Ferro, 2006, Inactivation of methicillin-resistant Staphylococcus aureus (MRSA) by liposome-delivered photosensitising agents, J. Photochem. Photobiol. B Biol., 83, 98, 10.1016/j.jphotobiol.2005.12.008 · doi:10.1016/j.jphotobiol.2005.12.008
  48. Ferro, 2007, Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome, Int. J. Biochem. Cell Biol., 39, 1026, 10.1016/j.biocel.2007.02.001 · DOI
  49. Ferro, 2009, Inclusion of 5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenylporphine in supramolecular aggregates of cationic amphiphilic cyclodextrins: physicochemical characterization of the complexes and strengthening of the antimicrobial photosensitizing activity, Biomacromolecules, 10, 2592, 10.1021/bm900533r · DOI
  50. Friedman, 2011, Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione, Nitric Oxide - Biol. Chem., 25, 381, 10.1016/j.niox.2011.09.001 · DOI
  51. Gao, 2017, Toxicity of nano- and ionic silver to embryonic stem cells: a comparative toxicogenomic study, J. Nanobiotech., 15, 31, 10.1186/s12951-017-0265-6 · DOI
  52. Garay-Jimenez, 2011, A convenient method to prepare emulsified polyacrylate nanoparticles from for drug delivery applications, Bioorg. Med. Chem. Lett., 21, 4589, 10.1016/j.bmcl.2011.05.104 · doi:10.1016/j.bmcl.2011.05.104
  53. Garay-Jimenez, 2008, Methods for purifying and detoxifying sodium dodecyl sulfate–stabilized polyacrylate nanoparticles, Nanomed. Nanotech. Biol. Med., 4, 98, 10.1016/j.nano.2008.03.004 · DOI
  54. Garay-Jimenez, 2009, Physical properties and biological activity of poly(butyl acrylate–styrene) nanoparticle emulsions prepared with conventional and polymerizable surfactants, Nanomed. Nanotech. Biol. Med., 5, 443, 10.1016/j.nano.2009.01.015 · doi:10.1016/j.nano.2009.01.015
  55. Gillies, 2005, Dendrimers and dendritic polymers in drug delivery, Drug Discov. Today, 10, 35, 10.1016/S1359-6446(04)03276-3 · DOI · Paper page
  56. Gil-Tomás, 2011, Lethal photosensitisation of bacteria using a tin chlorin E6–glutathione–gold nanoparticle conjugate, J. Mater. Chem., 21, 4189, 10.1039/c0jm03555f · doi:10.1039/c0jm03555f
  57. Gliga, 2014, Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release, Part. Fibre. Toxicol., 11, 10.1186/1743-8977-11-11 · DOI · Paper page
  58. Golubeva, 2011, Synthesis and study of antimicrobial activity of bioconjugates of silver nanoparticles and endogenous antibiotics, Glas. Phys. Chem., 37, 78, 10.1134/S1087659611010056 · DOI
  59. Goodyear, 2003, Death by a B cell superantigen: in vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin, J. Exp. Med., 197, 1125, 10.1084/jem.20020552 · DOI · Paper page
  60. Greenhalgh, 2009, In vivo studies of polyacrylate nanoparticle emulsions for topical and systemic applications, Nanomed. Nanotech. Biol. Med., 5, 46, 10.1016/j.nano.2008.07.004 · DOI
  61. Guhagarkar, 2009, Nanoparticles of polyethylene sebacate: a new biodegradable polymer, AAPS Pharm. Sci. Tech., 10, 935, 10.1208/s12249-009-9284-4 · DOI
  62. Guo, 2010, Rose bengal–decorated silica nanoparticles as photosensitizers for inactivation of gram-positive bacteria, Nanotechnology, 21, 1, 10.1088/0957-4484/21/6/065102 · doi:10.1088/0957-4484/21/6/065102
  63. Guzman, 2012, Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria, Nanomed. Nanotech. Biol. Med., 8, 37, 10.1016/j.nano.2011.05.007 · DOI · Paper page
  64. Hackenberg, 2011, Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells, Toxicol. Lett., 201, 27, 10.1016/j.toxlet.2010.12.001 · DOI · Paper page
  65. Han, 2009, Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection, PLoS One, 4, 1, 10.1371/journal.pone.0007804 · DOI
  66. Hess, 2003, Intracellular survival of Staphylococcus aureus within cultured enterocytes, J. Surg. Res., 114, 42, 10.1016/S0022-4804(03)00314-7 · DOI
  67. Holtz, 2010, Development of nanostructured silver vanadates decorated with silver nanoparticles as a novel antibacterial agent, Nanotechnology, 21, 1, 10.1088/0957-4484/21/18/185102 · DOI
  68. Holtz, 2012, Nanostructured silver vanadate as a promising antibacterial additive to water-based paints, Nanomed. Nanotech. Biol. Med., 8, 935, 10.1016/j.nano.2011.11.012 · DOI
  69. Huang, 2007, Functional gold nanoparticles as photothermal agents for selective-killing of pathogenic bacteria, Nanomedicine, 88, 548, 10.2217/17435889.2.6.777 · DOI · Paper page
  70. Huang, 2009, γ-Ray assisted synthesis of silver nanoparticles in chitosan solution and the antibacterial properties, Chem. Eng. J., 155, 499, 10.1016/j.cej.2009.07.040 · doi:10.1016/j.cej.2009.07.040
  71. Huang, 2010, Sucrose ester micellar-mediated synthesis of Ag nanoparticles and the antibacterial properties, Colloids Surf. A Physicochem. Eng. Asp., 353, 69, 10.1016/j.colsurfa.2009.10.023 · DOI
  72. Huang, 2011, Eradication of drug Resistant Staphylococcus aureus by liposomal oleic acids, Biomaterials, 32, 214, 10.1016/j.biomaterials.2010.08.076 · DOI · Paper page
  73. Huang, 2011, Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections, Antimicrob. Agents Chemother., 55, 3432, 10.1128/AAC.01803-10 · DOI · Paper page
  74. Huh, 2011, “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era, J. Control. Release, 156, 128, 10.1016/j.jconrel.2011.07.002 · DOI · Paper page
  75. Inoue, 2009, Antibacterial properties of nanostructured silver titanate thin films formed on a titanium plate, J. Biomed. Mater. Res. A, 92, 1171, 10.1002/jbm.a.32456 · doi:10.1002/jbm.a.32456
  76. Jain, 2010, Poly propyl ether imine (PETIM) dendrimer: a novel non-toxic dendrimer for sustained drug delivery, Eur. J. Med. Chem., 45, 4997, 10.1016/j.ejmech.2010.08.006 · doi:10.1016/j.ejmech.2010.08.006
  77. Jaspreet, 2005, Nanosystems in drug targeting: opportunities and challenges, Curr. Nanosci., 1, 48, 10.2174/1573413052953110 · DOI · Paper page
  78. Jevon, 1999, Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts, Infect Immun., 67, 2677, 10.1128/IAI.67.5.2677-2681.1999 · DOI · Paper page
  79. Jevons, 1961, “Celbenin”-resistant staphylococci, Br. Med. J., 1, 124, 10.1136/bmj.1.5219.124-a · DOI · Paper page
  80. Jiang, 2012, Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits, Inflamm. Res., 61, 207, 10.1007/s00011-011-0402-x · DOI
  81. Jones, 2008, Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms, FEMS Microbiol. Lett., 279, 71, 10.1111/j.1574-6968.2007.01012.x · DOI · Paper page
  82. Josefsson, 2005, The surface protein Pls of methicillin-resistant Staphylococcus aureus is a virulence factor in septic arthritis, Society, 73, 2812, 10.1128/IAI.73.5.2812-2817.2005 · doi:10.1128/iai.73.5.2812-2817.2005
  83. Kangwansupamonkon, 2009, Antibacterial Effect of Apatite-Coated Titanium Dioxide for Textiles Applications, Nanomed. Nanotech. Biol. Med., 5, 240, 10.1016/j.nano.2008.09.004 · DOI · Paper page
  84. Kathiresan, 2009, Studies on silver nanoparticles synthesized by a marine fungus, Penicillium fellutanum isolated from coastal mangrove sediment, Colloids Surf. B Biointerfaces, 71, 133, 10.1016/j.colsurfb.2009.01.016 · DOI · Paper page
  85. Kawata, 2009, In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells, Env. Sci. Tech., 43, 6046, 10.1021/es900754q · DOI · Paper page
  86. Kesharwani, 2017, Dendrimers in targeting and delivery of drugs, 363
  87. Kilian, 2011, Antimicrobial activity of liposome encapsulated cyclo(l-tyrosyl-l-prolyl), Pharmazie, 66, 421, 10.1691/ph.2011.0352 · doi:10.1691/ph.2011.0352
  88. Kim, 2010, Subchronic oral toxicity of silver nanoparticles, Part. Fibre. Toxicol., 7, 20, 10.1186/1743-8977-7-20 · DOI · Paper page
  89. Kim, 2013, Genotoxicity, acute oral and dermal toxicity, eye and dermal irritation and corrosion and skin sensitisation evaluation of silver nanoparticles, Nanotoxicology, 7, 953, 10.3109/17435390.2012.676099 · DOI
  90. Kreuter, 1991, Nanoparticle-based drug delivery systems, J. Control. Release, 16, 169, 10.1016/0168-3659(91)90040-K · DOI · Paper page
  91. Kumari, 2010, Biodegradable polymeric nanoparticles based drug delivery systems, Colloids Surf. B Biointerfaces, 75, 1, 10.1016/j.colsurfb.2009.09.001 · DOI · Paper page
  92. Kuo, 2009, Antimicrobial gold nanorods with dual-modality photodynamic inactivation and hyperthermia, Chem. Commun., 32, 4853, 10.1039/b907274h · DOI
  93. Kvítek, 2008, Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs), J. Phys. Chem. C, 112, 5825, 10.1021/jp711616v · DOI · Paper page
  94. Kvitek, 2011, Antibacterial activity and toxicity of silver—nanosilver versus ionic silver, J. Phys. Conf. Ser., 304, 12, 10.1088/1742-6596/304/1/012029 · DOI
  95. Labruère, 2010, Poly(vinyl benzoate) nanoparticles for molecular delivery: studies on their preparation and in vitro properties, J. Control. Release, 148, 234, 10.1016/j.jconrel.2010.08.016 · DOI
  96. Lankveld, 2010, The kinetics of the tissue distribution of silver nanoparticles of different sizes, Biomaterials, 31, 8350, 10.1016/j.biomaterials.2010.07.045 · DOI · Paper page
  97. Le, 2010, Photochemical synthesis of highly bactericidal silver nanoparticles, Nanotech. Russ., 5, 554, 10.1134/S1995078010070177 · DOI
  98. Lee, 2010, Comparison of the efficacies of silver-containing dressing materials for treating a full-thickness rodent wound infected by methicillin-resistant Staphylococcus aureus, Korean J. Lab. Med., 30, 20, 10.3343/kjlm.2010.30.1.20 · doi:10.3343/kjlm.2010.30.1.20
  99. Leid, 2012, In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria, J. Antimicrob. Chemother., 67, 138, 10.1093/jac/dkr408 · DOI · Paper page
  100. Li, 2014, Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria, ACS Nano, 8, 10682, 10.1021/nn5042625 · DOI · Paper page
  101. Liao, 2014, A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin, J. Am. Chem. Soc., 136, 5896, 10.1021/ja502011g · DOI · Paper page
  102. Liau, 1997, Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions, Lett. Appl. Microbio., 25, 279, 10.1046/j.1472-765X.1997.00219.x · DOI · Paper page
  103. Liu, 2009, Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent, Nat. Nanotechnol., 4, 457, 10.1038/nnano.2009.153 · DOI · Paper page
  104. Lowy, 1998, Staphylococcus aureus infections, N. Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
  105. Lowy, 2000, Is Staphylococcus aureus an intracellular pathogen, Trends Microbiol., 8, 341, 10.1016/S0966-842X(00)01803-5 · DOI · Paper page
  106. Lu, 2010, Effect of surface coating on the toxicity of silver nanomaterials on human skin keratinocytes, Chem. Phys. Lett., 487, 92, 10.1016/j.cplett.2010.01.027 · DOI · Paper page
  107. Lukowski, 2008, Inhibition of dermal MRSA colonization by microalgal micro- and nanoparticles, Skin Pharmacol. Physiol., 21, 98, 10.1159/000113066 · DOI
  108. Madhumathi, 2010, Development of novel chitin/nanosilver composite scaffolds for wound dressing applications, J. Mater. Sci. Mater. Med., 21, 807, 10.1007/s10856-009-3877-z · DOI · Paper page
  109. Majdalawieh, 2014, Recent advances in gold and silver nanoparticles: synthesis and applications, J. Nanosci. Nanotechnol., 14, 4757, 10.1166/jnn.2014.9526 · DOI · Paper page
  110. Maki, 2010, In vitro studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection, Clin. Infect. Dis., 50, 1580, 10.1086/652764 · DOI
  111. Martinez, 2009, Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection, J. Invest. Dermatol., 129, 2463, 10.1038/jid.2009.95 · DOI · Paper page
  112. Martins, 2010, Antitumoral activity of L-ascorbic acid-poly-D,L-(lactide-co-glycolide) nanoparticles containing violacein, Int. J. Nanomedicine, 5, 77, 10.2147/IJN.S7833 · DOI
  113. Matthews, 2010, Applications of nanomedicine in antibacterial medical therapeutics and diagnostics, Open Trop. Med. J., 3, 1, 10.2174/18743153010030100001 · DOI
  114. McCaig, 2006, Staphylococcus aureus–associated skin and soft tissue infections in ambulatory care, Emerg. Infect. Dis., 12, 1715, 10.3201/eid1211.060190 · DOI · Paper page
  115. Mei, 2014, Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG, Int. J. Pharm., 468, 26, 10.1016/j.ijpharm.2014.04.008 · DOI
  116. Meng, 2009, Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting MecA, Antimicrob. Agents Chemother., 53, 2871, 10.1128/AAC.01542-08 · DOI
  117. Mikklesen, 2011, Survey on basic knowledge about exposure and potential environmental and health risks for selected nanomaterials
  118. Mora-Huertas, 2010, Polymer-based nanocapsules for drug delivery, Int. J. Pharm., 385, 113, 10.1016/j.ijpharm.2009.10.018 · DOI · Paper page
  119. Moritz, 2013, The newest achievements in synthesis, immobilization and practical applications of antibacterial nanoparticles, Chem. Eng. J., 228, 596, 10.1016/j.cej.2013.05.046 · DOI · Paper page
  120. Nabikhan, 2010, Synthesis of antimicrobial silver nanoparticles by callus and leaf extracts from saltmarsh plant, Sesuvium portulacastrum L., Eng. Asp., 79, 488, 10.1016/j.colsurfb.2010.05.018 · DOI · Paper page
  121. Nanda, 2009, Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE, Nanomed. Nanotech. Biol. Med., 5, 452, 10.1016/j.nano.2009.01.012 · DOI · Paper page
  122. Necula, 2009, In vitro antibacterial activity of porous TiO2–Ag composite layers against methicillin-resistant Staphylococcus aureus, Acta Biomater., 5, 3573, 10.1016/j.actbio.2009.05.010 · doi:10.1016/j.actbio.2009.05.010
  123. Nederberg, 2011, Biodegradable nanostructures with selective lysis of microbial membranes, Nat. Chem., 3, 409, 10.1038/nchem.1012 · DOI · Paper page
  124. Nirmala, 2011, Synthesis and characterization of bovine femur bone hydroxyapatite containing silver nanoparticles for the biomedical applications, J. Nanoparticle Res., 13, 1917, 10.1007/s11051-010-9944-z · DOI
  125. Norrby, 2005, Lack of development of new antimicrobial drugs: a potential serious threat to public health, Lancet Infect. Dis., 5, 115, 10.1016/S1473-3099(05)70086-4 · doi:10.1016/s1473-3099(05)70086-4 · Paper page
  126. Onyeji, 1994, Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin, Infection, 22, 338, 10.1007/BF01715542 · DOI
  127. Pal, 2009, Synthesis of highly antibacterial nanocrystalline trivalent silver polydiguanide, J. Am. Chem. Soc., 131, 16147, 10.1021/ja9051125 · DOI
  128. Panacek, 2006, Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity, J. Phys. Chem. B, 110, 16248, 10.1021/jp063826h · DOI · Paper page
  129. Pangule, 2010, Anti-staphylococcal nanocomposite films based on enzyme–nanotube conjugates, ACS Nano, 4, 3993, 10.1021/nn100932t · DOI
  130. Park, 2013, Toxicokinetic differences and toxicities of silver nanoparticles and silver ions in rats after single oral administration, J. Toxicol. Environ. Health A, 76, 1246, 10.1080/15287394.2013.849635 · DOI
  131. Park, 2011, Size dependent macrophage responses and toxicological effects of Ag nanoparticles, Chem. Commun., 47, 4382, 10.1039/c1cc10357a · DOI · Paper page
  132. Park, 2011, Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats, Arch. Pharm. Res., 34, 153, 10.1007/s12272-011-0118-z · DOI · Paper page
  133. Park, 2011, The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles, Biomaterials, 32, 9810, 10.1016/j.biomaterials.2011.08.085 · DOI · Paper page
  134. Perelshtein, 2012, Enzymatic pre-treatment as a means of enhancing the antibacterial activity and stability of ZnO nanoparticles sonochemically coated on cotton fabrics, J. Mater. Chem., 22, 10736, 10.1039/c2jm31054f · DOI
  135. Perni, 2009, The antimicrobial properties of light-activated polymers containing methylene blue and gold nanoparticles, Biomaterials, 30, 89, 10.1016/j.biomaterials.2008.09.020 · DOI · Paper page
  136. Perni, 2011, Nanoparticles: their potential use in antibacterial photodynamic therapy, Photochem. Photobiol. Sci., 10, 712, 10.1039/c0pp00360c · DOI · Paper page
  137. Pinto-Alphandary, 2000, Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications, Int. J. Antimicrob. Agents, 13, 155, 10.1016/S0924-8579(99)00121-1 · DOI · Paper page
  138. Pissuwan, 2010, Functionalised gold nanoparticles for controlling pathogenic bacteria, Trends Biotechnol., 28, 207, 10.1016/j.tibtech.2009.12.004 · DOI · Paper page
  139. Pornpattananangkul, 2011, Bacterial toxin–triggered drug release from gold nanoparticle–stabilized liposomes for the treatment of bacterial infection, J. Am. Chem. Soc., 133, 4132, 10.1021/ja111110e · DOI · Paper page
  140. Potempa, 2009, Corruption of innate immunity by bacterial proteases, J. Innate Immun., 1, 70, 10.1159/000181144 · DOI · Paper page
  141. Prucek, 2011, The targeted antibacterial and antifungal properties of magnetic nanocomposite of iron oxide and silver nanoparticles, Biomaterials, 32, 4704, 10.1016/j.biomaterials.2011.03.039 · DOI · Paper page
  142. Pumerantz, 2011, Preparation of liposomal vancomycin and intracellular killing of methicillin-resistant Staphylococcus aureus (MRSA), Int. J. Antimicrob. Agents, 37, 140, 10.1016/j.ijantimicag.2010.10.011 · DOI
  143. Quang Huy, 2013, Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives, Adv. Nat. Sci., 4, 1, 10.1088/2043-6262/4/3/033001 · DOI · Paper page
  144. Raghunandan, 2011, Microwave-assisted rapid extracellular biosynthesis of silver nanoparticles using carom seed (Trachyspermum copticum) extract and in vitro studies, Am. J. Anal. Chem., 2, 475, 10.4236/ajac.2011.24057 · DOI
  145. Raghupathi, 2011, Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles, Langmuir, 27, 4020, 10.1021/la104825u · DOI · Paper page
  146. Rai, 2009, Silver nanoparticles as a new generation of antimicrobials, Biotechnol. Adv., 27, 76, 10.1016/j.biotechadv.2008.09.002 · DOI · Paper page
  147. Rathnayake, 2012, Synthesis and characterization of nano silver based natural rubber latex foam for imparting antibacterial and anti-fungal properties, Polym. Test., 31, 586, 10.1016/j.polymertesting.2012.01.010 · DOI
  148. Ray, 2005, In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(ε-caprolactone) microparticles, Antimicrob. Agents Chemother., 49, 3025, 10.1128/AAC.49.7.3025-3027.2005 · doi:10.1128/aac.49.7.3025-3027.2005
  149. Ren, 2009, Characterisation of copper oxide nanoparticles for antimicrobial applications, Int. J. Antimicrob. Agents, 33, 587, 10.1016/j.ijantimicag.2008.12.004 · DOI · Paper page
  150. Roy, 2010, Effect of nano–titanium dioxide with different antibiotics against methicillin-resistant Staphylococcus Aureus, J. Biomater. Nanobiotechnol., 1, 37, 10.4236/jbnb.2010.11005 · doi:10.4236/jbnb.2010.11005
  151. Samberg, 2010, Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro, Environ. Health Perspect., 118, 407, 10.1289/ehp.0901398 · DOI · Paper page
  152. Samberg, 2011, Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods, Nanotoxicology, 5, 244, 10.3109/17435390.2010.525669 · DOI
  153. Sande, 2012, Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model, J. Antimicrob. Chemother., 67, 2191, 10.1093/jac/dks212 · DOI
  154. Saravanan, 2010, Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSE, Colloids Surf. B Biointerfaces, 77, 214, 10.1016/j.colsurfb.2010.01.026 · doi:10.1016/j.colsurfb.2010.01.026
  155. Schairer, 2012, Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses, Virulence, 3, 62, 10.4161/viru.3.1.18816 · DOI
  156. Scoville, 2017, Genetic determinants of susceptibility to silver nanoparticle–induced acute lung inflammation in mice, Fed. Am. Soc. Exper. Biolog J., 31, 4600, 10.1096/fj.201700187R · DOI
  157. Sekhon, 2010, Inorganic nanomedicine—part 1, Nanomed. Nanotech. Biol. Med., 6, 516, 10.1016/j.nano.2010.04.004 · doi:10.1016/j.nano.2010.04.004
  158. Sekhon, 2010, Inorganic nanomedicine—part 2, Nanomed. Nanotech. Biol. Med., 6, 612, 10.1016/j.nano.2010.04.003 · DOI
  159. Shameli, 2010, Green synthesis of silver/montmorillonite/chitosan bionanocomposites using the UV irradiation method and evaluation of antibacterial activity, Int. J. Nanomedicine, 5, 875, 10.2147/IJN.S13632 · doi:10.2147/ijn.s13632
  160. Shameli, 2011, Fabrication of silver nanoparticles doped in the zeolite framework and antibacterial activity, Int. J. Nanomedicine, 6, 331, 10.2147/IJN.S16964 · doi:10.2147/ijn.s16964
  161. Shameli, 2011, Synthesis and characterization of silver/montmorillonite/chitosan bionanocomposites by chemical reduction method and their antibacterial activity, Int. J. Nanomedicine, 6, 271, 10.2147/IJN.S16043 · DOI · Paper page
  162. Sharma, 2009, Silver nanoparticles: green synthesis and their antimicrobial activities, Adv. Colloid Interface Sci., 145, 83, 10.1016/j.cis.2008.09.002 · DOI · Paper page
  163. Shastri, 2012, Antimicrobial activity of nanosilver-coated socks fabrics against foot pathogens, J. Text. Inst., 103, 1234, 10.1080/00405000.2012.675680 · DOI
  164. Sibbald, 2006, Mapping the pathways to staphylococcal pathogenesis by comparative secretomics, Microbiol. Mol. Biol. Rev., 70, 755, 10.1128/MMBR.00008-06 · DOI · Paper page
  165. Singh, 2012, Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles, Toxicol. Lett., 213, 249, 10.1016/j.toxlet.2012.07.009 · DOI · Paper page
  166. Son, 2007, Inorganic hollow nanoparticles and nanotubes in nanomedicine. Part 1. Drug/gene delivery applications, Drug Discov. Today, 12, 650, 10.1016/j.drudis.2007.06.002 · DOI · Paper page
  167. Son, 2007, Inorganic hollow nanoparticles and nanotubes in nanomedicine. Part 2: imaging, diagnostic, and therapeutic applications, Drug Discov. Today, 12, 657, 10.1016/j.drudis.2007.06.012 · DOI
  168. Stevanović, 2012, Poly(lactide-co-glycolide)/silver nanoparticles: synthesis, characterization, antimicrobial activity, cytotoxicity assessment and ROS-inducing potential, Polymer (United Kingdom), 53, 2818, 10.1016/j.polymer.2012.04.057 · DOI
  169. Stevens, 2011, Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters, Biomaterials, 32, 1264, 10.1016/j.biomaterials.2010.10.042 · DOI
  170. Stobie, 2009, Silver doped perfluoropolyether-urethane coatings: antibacterial activity and surface analysis, Colloids Surf. B Biointerfaces, 72, 62, 10.1016/j.colsurfb.2009.03.014 · doi:10.1016/j.colsurfb.2009.03.014
  171. Strohal, 2005, Nanocrystalline silver dressings as an efficient anti-MRSA Barrier: a new solution to an increasing problem, J. Hosp. Infect., 60, 226, 10.1016/j.jhin.2005.04.001 · DOI
  172. Su, 2009, The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay, Biomaterials, 30, 5979, 10.1016/j.biomaterials.2009.07.030 · DOI · Paper page
  173. Su, 2011, Novel nanohybrids of silver particles on clay platelets for inhibiting silver-resistant bacteria, PLoS One, 6, 1, 10.1371/journal.pone.0021125 · DOI
  174. Suleman, 2015, Silver salts of carboxylic acid terminated generation 1 poly(propyl ether imine) (PETIM) dendron and dendrimers as antimicrobial agents against S. Aureus and MRSA, RSC Adv., 5, 34967, 10.1039/C5RA03179F · DOI
  175. Suliman, 2013, Evaluation of cytotoxic, oxidative stress, proinflammatory and genotoxic effect of silver nanoparticles in human lung epithelial cells, Environ. Toxicol., 30, 149, 10.1002/tox.21880 · DOI
  176. Sung, 2009, Subchronic inhalation toxicity of silver nanoparticles, Toxicol. Sci., 108, 452, 10.1093/toxsci/kfn246 · DOI · Paper page
  177. Tang, 2009, Distribution, translocation and accumulation of silver nanoparticles in rats, J. Nanosci. Nanotechnol., 9, 4924, 10.1166/jnn.2009.1269 · DOI · Paper page
  178. Tang, 2015, Preparations of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells, J. Mater. Chem. B, 3, 6805, 10.1039/C5TB00912J · DOI
  179. Tsai, 2009, Improved photodynamic inactivation of gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles, Lasers Surg. Med., 41, 316, 10.1002/lsm.20754 · DOI
  180. Tuchscherr, 2011, Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection, EMBO Mol. Med., 3, 129, 10.1002/emmm.201000115 · DOI · Paper page
  181. Turos, 2007, Penicillin-bound polyacrylate nanoparticles: restoring the activity of β-lactam antibiotics against MRSA, Bioorg. Med. Chem. Lett., 17, 3468, 10.1016/j.bmcl.2007.03.077 · DOI
  182. Turos, 2007, Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents, Bioorg. Med. Chem. Lett., 17, 53, 10.1016/j.bmcl.2006.09.098 · DOI · Paper page
  183. Ulbrich, 2016, Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies, Chem. Rev., 116, 5338, 10.1021/acs.chemrev.5b00589 · DOI · Paper page
  184. Vanderesse, 2011, Nanoparticles for photodynamic therapy applications, 10.1007/978-94-007-1248-5_19 · DOI
  185. Vigderman, 2013, Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules, Adv. Drug Deliv. Rev., 65, 663, 10.1016/j.addr.2012.05.004 · DOI · Paper page
  186. Visage, 2001, Novel microparticulate system made of poly (methylidene malonate 2.1.2), Biomaterials, 22, 2229, 10.1016/S0142-9612(00)00411-7 · DOI
  187. Walsh, 2003, Where will new antibiotics come from, Nat. Rev. Microbiol., 1, 65, 10.1038/nrmicro727 · DOI · Paper page
  188. Walsh, 2004, A shot in the arm, Nature, 431, 892, 10.1038/431892a · DOI · Paper page
  189. Wang, 2011, Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study, Arch. Orthop. Trauma Surg., 131, 111, 10.1007/s00402-010-1154-8 · DOI
  190. Wang, 2015, Mesoporous silica nanoparticles in drug delivery and biomedical applications, Nanomed. Nanotech. Biol. Med., 11, 313, 10.1016/j.nano.2014.09.014 · DOI · Paper page
  191. Webster, 2006, Nanomedicine: what’s in a definition, Int. J. Nanomedicine, 1, 115, 10.2147/nano.2006.1.2.115 · doi:10.2147/nano.2006.1.2.115
  192. Williams, 1996, The glycopeptide story—how to kill the deadly “superbugs.”, 10.1039/NP9961300469 · DOI
  193. Wong, 2010, Silver nanoparticles—the real “silver bullet” in clinical medicine, Med. Chem. Comm., 1, 125, 10.1039/c0md00069h · DOI · Paper page
  194. Xu, 2006, Inorganic nanoparticles as carriers for efficient cellular delivery, Chem. Eng. Sci., 61, 1027, 10.1016/j.ces.2005.06.019 · DOI · Paper page
  195. Xue, 2015, Antimicrobial polymeric materials with quaternary ammonium and phosphonium salts, Int. J. Mol. Sci., 16, 3626, 10.3390/ijms16023626 · DOI · Paper page
  196. Yang, 2011, Antimicrobial peptide–modified liposomes for bacteria targeted delivery of temoporfin in photodynamic antimicrobial chemotherapy, Photochem. Photobiol. Sci., 10, 1593, 10.1039/c1pp05100h · DOI
  197. Yang, 2012, Wheat germ agglutinin modified liposomes for the photodynamic inactivation of bacteria, Photochem. Photobiol., 88, 548, 10.1111/j.1751-1097.2011.00983.x · DOI
  198. Yoshioka, 1981, Specific delivery of mitomycin C to the liver, spleen and lung: nano- and microspherical carriers of gelatin, Int. J. Pharm., 81, 131, 10.1016/0378-5173(81)90017-X · DOI
  199. You, 2014, Pharmacokinetics, clearance, and biosafety of polyethylene glycol–coated hollow gold nanospheres, 26
  200. Yu, 2007, Formation of colloidal silver nanoparticles stabilized by Na+-poly (γ-glutamic acid)–silver nitrate complex via chemical reduction process, Colloids Surf. B Biointerfaces, 59, 171, 10.1016/j.colsurfb.2007.05.007 · DOI · Paper page

200 of 204 shown

Metadata

Authors
Labruère, R., Sona, A. J., & Turos, E.
Venue
Frontiers in Pharmacology
Published
2019-10-04
Volume
10
ISSN
1663-9812
Cited by
53
References
11

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.